148 related articles for article (PubMed ID: 33862495)
21. Early matrix metalloproteinase-9 inhibition post-myocardial infarction worsens cardiac dysfunction by delaying inflammation resolution.
Iyer RP; de Castro Brás LE; Patterson NL; Bhowmick M; Flynn ER; Asher M; Cannon PL; Deleon-Pennell KY; Fields GB; Lindsey ML
J Mol Cell Cardiol; 2016 Nov; 100():109-117. PubMed ID: 27746126
[TBL] [Abstract][Full Text] [Related]
22. Lipoxygenase drives lipidomic and metabolic reprogramming in ischemic heart failure.
Halade GV; Kain V; Tourki B; Jadapalli JK
Metabolism; 2019 Jul; 96():22-32. PubMed ID: 30999004
[TBL] [Abstract][Full Text] [Related]
23. The different inhibitory effects of Huang-Lian-Jie-Du-Tang on cyclooxygenase 2 and 5-lipoxygenase.
Li L; Zeng H; Shan L; Yuan X; Li Y; Liu R; Zhang W
J Ethnopharmacol; 2012 Sep; 143(2):732-9. PubMed ID: 22884869
[TBL] [Abstract][Full Text] [Related]
24. Enhanced monocyte recruitment and delayed alternative macrophage polarization accompanies impaired repair following myocardial infarction in C57BL/6 compared to BALB/c mice.
Toor IS; Rückerl D; Mair I; Thomson A; Rossi AG; Newby DE; Allen JE; Gray GA
Clin Exp Immunol; 2019 Oct; 198(1):83-93. PubMed ID: 31119724
[TBL] [Abstract][Full Text] [Related]
25. [Antagonistic effect of 12-lipoxygenase inhibitor ML355 on lipopolysaccharide induced inflammatory response in mice].
Wang X; Tang W; Chen T; Luo L; Liang H
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Nov; 32(11):1378-1384. PubMed ID: 33463501
[TBL] [Abstract][Full Text] [Related]
26. 12/15-Lipoxygenase Inhibition or Knockout Reduces Warfarin-Associated Hemorrhagic Transformation After Experimental Stroke.
Liu Y; Zheng Y; Karatas H; Wang X; Foerch C; Lo EH; van Leyen K
Stroke; 2017 Feb; 48(2):445-451. PubMed ID: 28057806
[TBL] [Abstract][Full Text] [Related]
27. Azithromycin therapy reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction: Potential therapeutic targets in ischemic heart disease.
Al-Darraji A; Haydar D; Chelvarajan L; Tripathi H; Levitan B; Gao E; Venditto VJ; Gensel JC; Feola DJ; Abdel-Latif A
PLoS One; 2018; 13(7):e0200474. PubMed ID: 30001416
[TBL] [Abstract][Full Text] [Related]
28. Resolution Agonist 15-epi-Lipoxin A
Kain V; Liu F; Kozlovskaya V; Ingle KA; Bolisetty S; Agarwal A; Khedkar S; Prabhu SD; Kharlampieva E; Halade GV
Sci Rep; 2017 Aug; 7(1):9999. PubMed ID: 28855632
[TBL] [Abstract][Full Text] [Related]
29. Protective role of resolvin D1, a pro-resolving lipid mediator, in nonsteroidal anti-inflammatory drug-induced small intestinal damage.
Kuzumoto T; Tanigawa T; Higashimori A; Kitamura H; Nadatani Y; Otani K; Fukunaga S; Hosomi S; Tanaka F; Kamata N; Nagami Y; Taira K; Watanabe T; Fujiwara Y
PLoS One; 2021; 16(5):e0250862. PubMed ID: 33945545
[TBL] [Abstract][Full Text] [Related]
30. Identification of 4-[4-(4-fluoro-phenyl)-thiazol-2-ylamino]-2,6-dimethyl-phenol (KR-33749) as an inhibitor of 5-lipoxygenase with potent antiinflammatory activity.
Cho YS; Kim CH; Surh JH; Kang NS; Yoo SE; Cheon HG
Pharmacology; 2010; 86(2):65-72. PubMed ID: 20639685
[TBL] [Abstract][Full Text] [Related]
31. 12/15-Lipoxygenase regulates the inflammatory response to bacterial products in vivo.
Dioszeghy V; Rosas M; Maskrey BH; Colmont C; Topley N; Chaitidis P; Kühn H; Jones SA; Taylor PR; O'Donnell VB
J Immunol; 2008 Nov; 181(9):6514-24. PubMed ID: 18941242
[TBL] [Abstract][Full Text] [Related]
32. Lgr4 Governs a Pro-Inflammatory Program in Macrophages to Antagonize Post-Infarction Cardiac Repair.
Huang CK; Dai D; Xie H; Zhu Z; Hu J; Su M; Liu M; Lu L; Shen W; Ning G; Wang J; Zhang R; Yan X
Circ Res; 2020 Sep; 127(8):953-973. PubMed ID: 32600176
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin-converting enzyme inhibitor treatment early after myocardial infarction attenuates acute cardiac and neuroinflammation without effect on chronic neuroinflammation.
Borchert T; Hess A; Lukačević M; Ross TL; Bengel FM; Thackeray JT
Eur J Nucl Med Mol Imaging; 2020 Jul; 47(7):1757-1768. PubMed ID: 32125488
[TBL] [Abstract][Full Text] [Related]
34. Exogenous IL-4 shuts off pro-inflammation in neutrophils while stimulating anti-inflammation in macrophages to induce neutrophil phagocytosis following myocardial infarction.
Daseke MJ; Tenkorang-Impraim MAA; Ma Y; Chalise U; Konfrst SR; Garrett MR; DeLeon-Pennell KY; Lindsey ML
J Mol Cell Cardiol; 2020 Aug; 145():112-121. PubMed ID: 32574573
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of spinal 15-LOX-1 attenuates TLR4-dependent, nonsteroidal anti-inflammatory drug-unresponsive hyperalgesia in male rats.
Gregus AM; Buczynski MW; Dumlao DS; Norris PC; Rai G; Simeonov A; Maloney DJ; Jadhav A; Xu Q; Wei SC; Fitzsimmons BL; Dennis EA; Yaksh TL
Pain; 2018 Dec; 159(12):2620-2629. PubMed ID: 30130298
[TBL] [Abstract][Full Text] [Related]
36. Cardiac 12/15 lipoxygenase-induced inflammation is involved in heart failure.
Kayama Y; Minamino T; Toko H; Sakamoto M; Shimizu I; Takahashi H; Okada S; Tateno K; Moriya J; Yokoyama M; Nojima A; Yoshimura M; Egashira K; Aburatani H; Komuro I
J Exp Med; 2009 Jul; 206(7):1565-74. PubMed ID: 19546247
[TBL] [Abstract][Full Text] [Related]
37. Long-Term Administration of Eicosapentaenoic Acid Improves Post-Myocardial Infarction Cardiac Remodeling in Mice by Regulating Macrophage Polarization.
Takamura M; Kurokawa K; Ootsuji H; Inoue O; Okada H; Nomura A; Kaneko S; Usui S
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28223437
[TBL] [Abstract][Full Text] [Related]
38. Compromised Anti-inflammatory Action of Neutrophil Extracellular Traps in PAD4-Deficient Mice Contributes to Aggravated Acute Inflammation After Myocardial Infarction.
Eghbalzadeh K; Georgi L; Louis T; Zhao H; Keser U; Weber C; Mollenhauer M; Conforti A; Wahlers T; Paunel-Görgülü A
Front Immunol; 2019; 10():2313. PubMed ID: 31632398
[TBL] [Abstract][Full Text] [Related]
39. Early treatment with Resolvin E1 facilitates myocardial recovery from ischaemia in mice.
Liu G; Liu Q; Shen Y; Kong D; Gong Y; Tao B; Chen G; Guo S; Li J; Zuo S; Yu Y; Yin H; Zhang L; Zhou B; Funk CD; Zhang J; Yu Y
Br J Pharmacol; 2018 Apr; 175(8):1205-1216. PubMed ID: 28925017
[TBL] [Abstract][Full Text] [Related]
40. Rational Development of a Potent 15-Lipoxygenase-1 Inhibitor with in Vitro and ex Vivo Anti-inflammatory Properties.
Eleftheriadis N; Neochoritis CG; Leus NG; van der Wouden PE; Dömling A; Dekker FJ
J Med Chem; 2015 Oct; 58(19):7850-62. PubMed ID: 26331552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
